AI-assisted, human-published
06/16/2026 /Funding Events
Kos Biotechnology Partners Successfully Closes $123M Global Life Sciences Fund
Kos Biotechnology Partners completes third fund closing, raising $123 million with support from institutional investors and family offices, marking a milestone in Greece's venture capital landscape.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com